These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34632160)

  • 1. SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
    Darvishi M; Rahimi F; Talebi Bezmin Abadi A
    Gene Rep; 2021 Dec; 25():101378. PubMed ID: 34632160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    bioRxiv; 2021 Aug; ():. PubMed ID: 34462749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.
    Akkız H
    Front Med (Lausanne); 2022; 9():849217. PubMed ID: 35669924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein.
    La Rosa G; Mancini P; Bonanno Ferraro G; Veneri C; Iaconelli M; Lucentini L; Bonadonna L; Brusaferro S; Brandtner D; Fasanella A; Pace L; Parisi A; Galante D; Suffredini E
    Water Res; 2021 Jun; 197():117104. PubMed ID: 33857895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Variants in Paraguay: Detection and Surveillance with an Economical and Scalable Molecular Protocol.
    Martinez M; Nguyen PV; Su M; Cardozo F; Valenzuela A; Franco L; Galeano ME; Rojas LE; Díaz Acosta CC; Fernández J; Ortiz J; Del Puerto F; Mendoza L; Nara E; Rojas A; Waggoner JJ
    Viruses; 2022 Apr; 14(5):. PubMed ID: 35632615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 worldwide replication drives rapid rise and selection of mutations across the viral genome: a time-course study - potential challenge for vaccines and therapies.
    Weber S; Ramirez CM; Weiser B; Burger H; Doerfler W
    EMBO Mol Med; 2021 Jun; 13(6):e14062. PubMed ID: 33931941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic monitoring unveil the early detection of the SARS-CoV-2 B.1.351 (beta) variant (20H/501Y.V2) in Brazil.
    Slavov SN; Patané JSL; Bezerra RDS; Giovanetti M; Fonseca V; Martins AJ; Viala VL; Rodrigues ES; Santos EV; Barros CRS; Marqueze EC; Santos B; Aburjaile F; Neto RM; Moretti DB; Haddad R; Calado RT; Kitajima JP; Freitas E; Schlesinger D; Junior de Alcantara LC; Elias MC; Sampaio SC; Kashima S; Covas DT
    J Med Virol; 2021 Dec; 93(12):6782-6787. PubMed ID: 34241897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
    Jia Z; Gong W
    J Korean Med Sci; 2021 May; 36(18):e124. PubMed ID: 33975397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging SARS-CoV-2 variants of concern.
    Sanyaolu A; Okorie C; Marinkovic A; Haider N; Abbasi AF; Jaferi U; Prakash S; Balendra V
    Ther Adv Infect Dis; 2021; 8():20499361211024372. PubMed ID: 34211709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications.
    Singh J; Samal J; Kumar V; Sharma J; Agrawal U; Ehtesham NZ; Sundar D; Rahman SA; Hira S; Hasnain SE
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33803400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Neutralizing Activity of mRNA-1273 against SARS-CoV-2 Variants.
    Choi A; Koch M; Wu K; Dixon G; Oestreicher J; Legault H; Stewart-Jones GBE; Colpitts T; Pajon R; Bennett H; Carfi A; Edwards DK
    J Virol; 2021 Nov; 95(23):e0131321. PubMed ID: 34549975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live Virus Neutralisation of the 501Y.V1 and 501Y.V2 SARS-CoV-2 Variants following INO-4800 Vaccination of Ferrets.
    Riddell S; Goldie S; McAuley AJ; Kuiper MJ; Durr PA; Blasdell KR; Tachedjian M; Druce JD; Smith TRF; Broderick KE; Vasan SS
    Front Immunol; 2021; 12():694857. PubMed ID: 34248993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H.
    Zeng C; Evans JP; Faraone JN; Qu P; Zheng YM; Saif L; Oltz EM; Lozanski G; Gumina RJ; Liu SL
    mBio; 2021 Oct; 12(5):e0251021. PubMed ID: 34607452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SARS-CoV-2 variants, a still unfinished story].
    Pérez-Abeledo M; Sanz Moreno JC
    Vacunas; 2021; 22(3):173-179. PubMed ID: 34276267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Possible Role of Remdesivir and Plasma Therapy in the Selective Sweep and Emergence of New SARS-CoV-2 Variants.
    Colson P; Devaux CA; Lagier JC; Gautret P; Raoult D
    J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-COV-2 Variants: Differences and Potential of Immune Evasion.
    Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL
    Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
    Yang W; Shaman J
    medRxiv; 2021 Nov; ():. PubMed ID: 34845460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.